Shanghai Harvest Medical Technology

Harvest Medical is a medical technology company focused on the development of innovative neurointerventional devices for the treatment of stroke and other cerebrovascular diseases. The company's product portfolio includes a full suite of solutions for ischemic and hemorrhagic stroke, such as stent retrievers, aspiration catheters, and distal access catheters. Harvest Medical operates R&D centers in both China and Singapore, leveraging global expertise to bring advanced interventional therapies to market. Their flagship Trando Stent Retriever and Afentta Balloon Catheter have received NMPA approval, establishing the company as a significant player in the neurovascular intervention space. Backed by prominent investors like Hillhouse and Sequoia China, Harvest Medical is positioned as a key domestic player in China's high-end medical device sector.